1. Home
  2. EVO vs REX Comparison

EVO vs REX Comparison

Compare EVO & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.65

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo REX American Resources Corporation

REX

REX American Resources Corporation

HOLD

Current Price

$32.49

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
REX
Founded
1993
1980
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
EVO
REX
Price
$3.65
$32.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$25.00
AVG Volume (30 Days)
251.6K
231.0K
Earning Date
11-05-2025
12-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.48
Revenue
$887,396,457.00
$650,756,000.00
Revenue This Year
N/A
$3.27
Revenue Next Year
$8.52
$17.11
P/E Ratio
N/A
$21.48
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$16.73
52 Week High
$4.80
$36.50

Technical Indicators

Market Signals
Indicator
EVO
REX
Relative Strength Index (RSI) 71.06 45.22
Support Level $3.10 $31.26
Resistance Level $3.23 $33.41
Average True Range (ATR) 0.08 0.90
MACD 0.08 -0.19
Stochastic Oscillator 96.87 32.88

Price Performance

Historical Comparison
EVO
REX

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About REX REX American Resources Corporation

REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.

Share on Social Networks: